| scholarly article | Q13442814 |
| P2093 | author name string | I M Gould | |
| K E N Milne | |||
| P2860 | cites work | Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia | Q24533461 |
| Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders | Q33608581 | ||
| Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy | Q33697276 | ||
| The changing microbial epidemiology in cystic fibrosis | Q33825634 | ||
| Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains. | Q33982141 | ||
| Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis | Q34686580 | ||
| Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis | Q35005445 | ||
| Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis | Q35554403 | ||
| Advances in cystic fibrosis therapies | Q36651319 | ||
| Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis | Q36771148 | ||
| Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'. | Q36942205 | ||
| Aerosol antibiotics: considerations in pharmacological and clinical evaluation | Q37335650 | ||
| In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia | Q43028077 | ||
| Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index | Q43253862 | ||
| Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199 | Q43587149 | ||
| In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations | Q43785359 | ||
| In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods | Q43875969 | ||
| In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa | Q44266808 | ||
| Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection. | Q44275415 | ||
| Antibiograms of resistant Gram-negative bacteria from Scottish CF patients | Q45089005 | ||
| Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods | Q45241892 | ||
| Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients. | Q47249113 | ||
| Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. | Q51425115 | ||
| Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. | Q51708622 | ||
| Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. | Q53946782 | ||
| Identification and management of unusual pathogens in cystic fibrosis | Q57913664 | ||
| Combination antibiotic susceptibility testing in cystic fibrosis | Q59465642 | ||
| Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates | Q60169831 | ||
| Synergy, antagonism, and what the chequerboard puts between them | Q73521098 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Stenotrophomonas maltophilia | Q142705 |
| cystic fibrosis | Q178194 | ||
| multiple drug resistance | Q643839 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 4071-4077 | |
| P577 | publication date | 2012-05-14 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients | |
| P478 | volume | 56 |
| Q33675580 | A synergistic effect of artocarpanone from Artocarpus heterophyllus L. (Moraceae) on the antibacterial activity of selected antibiotics and cell membrane permeability |
| Q42003718 | Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia |
| Q35230652 | Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis |
| Q27014993 | Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy |
| Q47117969 | Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt |
| Q40303008 | Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital |
| Q40206558 | Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacterbaumannii |
| Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
| Q37597229 | Genomic sequence of temperate phage Smp131 of Stenotrophomonas maltophilia that has similar prophages in xanthomonads |
| Q42272359 | Multidrug-resistant gram-negative bacteria infections in solid organ transplantation |
| Q45099898 | New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen |
| Q50013423 | Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis |
| Q47820779 | Stenotrophomonas maltophilia Serine Protease StmPr1 Induces Matrilysis, Anoikis, and Protease-Activated Receptor 2 Activation in Human Lung Epithelial Cells |
| Q37203771 | Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient |
| Q37366281 | Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy |
| Q51026097 | Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria. |
| Q50928904 | Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. |
| Q38130513 | The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection. |
| Q47661746 | Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy |
| Q36053562 | Type II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2 |
| Q26782924 | Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options |
Search more.